Marinus Pharmaceuticals, Inc. logo

Marinus Pharmaceuticals, Inc.

NASDAQ:MRNS

Overview | Financials
Company Name Marinus Pharmaceuticals, Inc.
Symbol MRNS
Currency USD
Price 0.359
Market Cap 19,775,156
Dividend Yield 0%
52-week-range 0.26 - 11.26
Industry Biotechnology
Sector Healthcare
CEO Dr. Scott N. Braunstein M.D.
Website https://marinuspharma.com

An error occurred while fetching data.

About Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute

Related Stocks

MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX

50.67 USD

Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

PLRX

15.19 USD

DermTech, Inc. logo

DermTech, Inc.

DMTK

0.094 USD

Immunic, Inc. logo

Immunic, Inc.

IMUX

1.18 USD

Kronos Bio, Inc. logo

Kronos Bio, Inc.

KRON

0.9 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

4.32 USD

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

33.91 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

0.265 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

15.255 USD

Financials

Numbers are in millions USD

Numbers are in millions USD